J&J’s New Insider CEO Brings Expertise From Crucial Pharma Post

Aug. 20, 2021, 3:20 PM UTC

Johnson & Johnson went to another insider to lead the health-care giant through the pandemic, naming Joaquin Duato to replace longtime veteran Alex Gorsky, and edging up the stock to a record high.

Now vice chairman of the executive committee, Duato will take the reins effective Jan. 3 and take a seat on the company’s board, J&J said in a statement late Thursday. Gorsky, who’s been at the helm for nine years, will become executive chairman.

Joaquin Duato
Photographer: Andrew Harrer/Bloomberg

Duato, 59, is a three-decade veteran of J&J, as is Gorsky. He has served in his current role since 2018, guiding the ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.